Letrozole ( DrugBank: Letrozole )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
81	Congenital adrenal hyperplasia	1
89	Lymphangioleiomyomatosis	1

81. Congenital adrenal hyperplasia

---

Clinical trials : 88 /  Drugs : 90 - (DrugBank : 23) / Drug target genes : 12 - Drug target pathways : 68

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00001521 (ClinicalTrials.gov)	June 8, 1995	3/11/1999	Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia	An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children With Congenital Adrenal Hyperplasia	Congenital Adrenal Hyperplasia (CAH)	Drug: Flutamide;Drug: Letrozole;Drug: Hydrocortisone;Drug: Fludrocortisone	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	NULL	Active, not recruiting	2 Years	18 Years	All	62	Phase 2	United States

89. Lymphangioleiomyomatosis

---

Clinical trials : 39 /  Drugs : 46 - (DrugBank : 20) / Drug target genes : 27 - Drug target pathways : 137

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01353209 (ClinicalTrials.gov)	May 2011	11/5/2011	Trial of Aromatase Inhibition in Lymphangioleiomyomatosis	A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS	Lymphangioleiomyomatosis	Drug: Letrozole;Drug: Placebo	University of Cincinnati	Department of Defense	Completed	18 Years	N/A	Female	17	Phase 2	United States